H.C. Wainwright Initiates a Buy Rating on Balchem Corp (BCPC)


H.C. Wainwright analyst Ram Selvaraju initiated coverage with a Buy rating on Balchem Corp (NASDAQ: BCPC) today and set a price target of $140. The company’s shares closed yesterday at $114.97, close to its 52-week high of $117.79.

According to TipRanks.com, Selvaraju is a 4-star analyst with an average return of 5.7% and a 44.5% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Biospecifics Technologies Corp, EyePoint Pharmaceuticals Inc, and Bausch Health Companies Inc.

Currently, the analyst consensus on Balchem Corp is a Moderate Buy with an average price target of $117.50.

See today’s analyst top recommended stocks >>

The company has a one-year high of $117.79 and a one-year low of $70.23. Currently, Balchem Corp has an average volume of 91.87K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Balchem Corp. engages in the development, manufacture, and marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, Specialty Products, and Industrial Products.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts